Business Context and Reporting Period
This Form 8-K Current Report was filed by AUDIOEYE INC on March 3, 2025, with the report date reflecting events occurring on March 3 and March 4, 2025. The filing addresses corporate governance changes, specifically the departure of a director and the election of a new director.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Director Resignation: Anthony Coelho resigned as a director of the Company, effective March 3, 2025.
- Director Election: The Board elected James B. Hawkins to fill the vacancy created by Mr. Coelho's resignation. Mr. Hawkins will serve until the 2025 Annual Meeting of Stockholders or until his successor is elected.
- Committee Appointments: Mr. Hawkins was appointed to the Audit Committee, the Compensation Committee, and the Nominating and Corporate Governance Committee, effective March 3, 2025.
Guidance, Outlook, and Management Commentary
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It includes a brief biography of the new director, James B. Hawkins, noting his prior experience as President and CEO of Natus Medical (2004–2018) and CEO of Invivo Corporation. The filing confirms there are no family relationships between Mr. Hawkins and other directors or officers and no undisclosed transactions.
Compensation Arrangements: As a non-employee director, Mr. Hawkins will receive pro-rated restricted stock units (RSUs) for his annual and quarterly equity awards covering the period from March 3, 2025, to May 23, 2025, and March 31, 2025, respectively, consistent with the Company's 2024 Proxy Statement.
Investor Verification Checklist
- Verify the effective date of Anthony Coelho's resignation and James B. Hawkins' appointment (March 3, 2025).
- Confirm Mr. Hawkins' specific committee assignments (Audit, Compensation, Nominating and Corporate Governance).
- Review the 2024 Proxy Statement for details on the non-employee director compensation structure referenced for Mr. Hawkins' RSU awards.
- Check for any subsequent filings regarding the 2025 Annual Meeting of Stockholders where Mr. Hawkins' term will be subject to election.